- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 18.12. | Intelligent Bio Solutions forms alliance with Vlepis to enter health monitoring | 7 | Investing.com | ||
| 18.12. | Intelligent Bio Solutions schließt Allianz mit Vlepis für Einstieg in den Markt für Gesundheitsmonitoring | 2 | Investing.com Deutsch | ||
| 16.12. | Intelligent Bio Solutions erhält Rüge der NASDAQ und führt Aktienzusammenlegung durch | 4 | Investing.com Deutsch | ||
| 12.12. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | - | SEC Filings | ||
| 12.12. | Intelligent Bio Solutions kündigt Aktienzusammenlegung im Verhältnis 1:10 an | 3 | Investing.com Deutsch | ||
| 12.12. | Intelligent Bio Solutions to implement 1-for-10 reverse stock split | 2 | Investing.com | ||
| INTELLIGENT BIO SOLUTIONS Aktie jetzt für 0€ handeln | |||||
| 12.12. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Inc. Announces Reverse Stock Split | 290 | GlobeNewswire (Europe) | NEW YORK, Dec. 12, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("Intelligent Bio Solutions" or the "Company"), a medical technology company delivering intelligent, rapid... ► Artikel lesen | |
| 05.12. | INTELLIGENT BIO SOLUTIONS INC. - S-8, Securities to be offered to employees in employee benefit plans | 3 | SEC Filings | ||
| 28.11. | Intelligent Bio Solutions vergütet Beratungsdienste mit 75.000 gesperrten Aktien | 3 | Investing.com Deutsch | ||
| 28.11. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | - | SEC Filings | ||
| 20.11. | Noble Financial Group, Inc.: Intelligent Bio Solutions to Participate in Noble Capital Markets' 21st Annual Emerging Growth Equity Conference on December 2-3, 2025 | 385 | Newsfile | New York, New York--(Newsfile Corp. - November 20, 2025) - Intelligent Bio Solutions Inc. (NASDAQ: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive... ► Artikel lesen | |
| 12.11. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Reports Fiscal 2026 First Quarter Financial Results and Operational Highlights, Delivering Record Revenue Growth | 173 | GlobeNewswire (Europe) | Record quarterly revenue of $1.11 million, an increase of 32% sequentially and 28% year-over-year, driven by consumable cartridge sales and customer base expansion Gross profit margins increased 690... ► Artikel lesen | |
| 12.11. | INTELLIGENT BIO SOLUTIONS INC. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 07.11. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 6 | SEC Filings | ||
| 04.11. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Expects to Report Record Fiscal First Quarter 2026 Revenue of Over $1 Million, an Increase of Approximately 32% Sequentially and 28% Year-Over-Year | 12 | GlobeNewswire (USA) | ||
| 30.10. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 3 | SEC Filings | ||
| 30.10. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Secures 33 New Customer Accounts in the Fiscal 2026 First Quarter, Showing Strong Year-Over-Year Growth and Increasing Total Active Accounts to 480 | 245 | GlobeNewswire (Europe) | NEW YORK, Oct. 30, 2025 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing... ► Artikel lesen | |
| 23.10. | UK industrial service provider adopts INBS drug testing technology | 2 | Investing.com | ||
| 23.10. | Intelligent Bio Solutions, Inc.: Intelligent Bio Solutions Secures Major UK Contract with Multinational Industrial Service Provider | 227 | GlobeNewswire (Europe) | Multinational company employs approximately 3,000 staff within the UK and Ireland and more than 30,000 staff worldwide Large new customer account highlights accelerating adoption of the Company's... ► Artikel lesen | |
| 21.10. | INTELLIGENT BIO SOLUTIONS INC. - 8-K, Current Report | 8 | SEC Filings |
1 2 3 4 Weiter >>
63 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ECKERT & ZIEGLER | 14,970 | +2,39 % | Morgen-Update: Eckert&Ziegler schockt die Skeptiker - Kurs geht durch die Decke! | ||
| DRAEGERWERK | 68,70 | +0,44 % | EQS-News: Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener Aktien - Abschlussmeldung | EQS-News: Drägerwerk AG & Co. KGaA
/ Schlagwort(e): Sonstiges
Drägerwerk AG & Co. KGaA: Bekanntmachung nach Art. 5 Abs. 1 und Abs. 3 der Verordnung (EU) Nr. 596/2014: Erwerb eigener... ► Artikel lesen | |
| TELADOC HEALTH | 6,056 | -2,07 % | HIMS vs. TDOC: Which Telehealth Stock Looks More Compelling? | ||
| ROKU | 92,81 | -2,10 % | Nielsen To Incorporate Roku's Data Into Its Advanced Campaign Measurement And Outcome Solutions | WASHINGTON (dpa-AFX) - Nielsen, a global data, analytics, and audience measurement company, has expanded its long-term strategic partnership with Roku, Inc. (ROKU) to incorporate the latter's... ► Artikel lesen | |
| HIMS & HERS HEALTH | 29,580 | -0,30 % | Hims & Hers Expands Subscription-Led Care as Platform Engagement Grows | ||
| BICO GROUP | 1,749 | +2,46 % | BICO Group AB: Jesper Hagberg appointed as Chief Operations & Digital Officer for BICO Group AB | BICO Group AB today announces the appointment of Jesper Hagberg as Chief Operations & Digital Officer.
Jesper Hagberg brings over 25 years of experience as CIO, CDO and Transformation Leader, driving... ► Artikel lesen | |
| SERNOVA BIOTHERAPEUTICS | 0,082 | +3,16 % | Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts | Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine... ► Artikel lesen | |
| GERATHERM MEDICAL | 2,820 | -2,76 % | Geratherm Medical AG: Starkes Wachstum im ersten Halbjahr und operatives Break-even; KAUFEN bestätigt. | Geratherm verzeichnete im ersten Halbjahr 2025 ein starkes Wachstum: Die vergleichbaren Umsätze stiegen um 13,2 % gegenüber dem Vorjahr und sequenziell um 15,4 %. Getrieben wurde dieses Wachstum von... ► Artikel lesen | |
| SYNLAB | 12,710 | 0,00 % | EQS-News: SYNLAB AG: Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort | EQS-News: SYNLAB
/ Schlagwort(e): Strategische Unternehmensentscheidung
Weitere Investitionen in Italien für modernste Diagnostik und Patientenkomfort
23.10.2025... ► Artikel lesen | |
| ALIGN TECHNOLOGY | 132,30 | -2,04 % | TECX, GKOS, GH, ALGN, NMRA Surge After Hours On Clinical Data And Earnings | WASHINGTON (dpa-AFX) - Several healthcare and life sciences names posted notable gains in after-hours trading, driven by clinical updates, earnings releases, and in some cases, unexplained momentum.Tectonic... ► Artikel lesen | |
| NUGEN MEDICAL DEVICES | 0,016 | -11,11 % | NuGen Medical: Kurs explodiert nach wichtiger News! | ||
| PLUS THERAPEUTICS | 0,580 | +2,08 % | Plus Therapeutics Inc.: Plus Therapeutics Announces Completion of U.S. FDA Meeting on Future Clinical Development Plans for REYOBIQ in Leptomeningeal Metastases | HOUSTON, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the "Company"), a healthcare company developing and commercializing precision diagnostics and radiopharmaceuticals... ► Artikel lesen | |
| HEALWELL AI | 0,493 | -5,19 % | HEALWELL AI beruft Ian Kidson in sein Board of Directors | - HEALWELL holt Ian Kidson, einen erfahrenen Führungsexperten und Direktor mit jahrzehntelanger Erfahrung in Finanzwesen, Governance und Betriebsführung im Gesundheitswesen,
in sein... ► Artikel lesen | |
| ATOSSA THERAPEUTICS | 0,600 | -0,83 % | Atossa Therapeutics Inc: Atossa Therapeutics Receives FDA Rare Pediatric Disease Designation for (Z)-Endoxifen for Duchenne Muscular Dystrophy | Designation expands (Z)-Endoxifen program into rare pediatric neuromuscular disease and may qualify Atossa for a future Priority Review Voucher upon approval
SEATTLE... ► Artikel lesen | |
| SPINEWAY | 0,141 | +2,47 % | Spineway: Revenue growth in the third quarter | Ecully, October 14, 2025 - 6:30 p.m. SPINEWAYRevenue growth in the third quarter In thousands of euros20252024Change as a %Q3 revenue3,0452,575 +18%Q2 revenue2,7453,465-21% Q1 revenue2,8283,070-8%9M... ► Artikel lesen |
INTELLIGENT BIO SOLUTIONS INC gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von -0,140 (-2,81 %) liegt der Kurs bei 4,840 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu INTELLIGENT BIO SOLUTIONS INC finden Sie auf Wallstreet Online.